Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07424911

α-N-acetylgalactosaminidase Levels in Panic Disorder

Sponsor: Elazığ Mental Health and Diseases Hospital

View on ClinicalTrials.gov

Summary

This prospective observational cohort study investigated serum α-N-acetylgalactosaminidase levels in drug-naïve patients with Panic Disorder (PD) at baseline and after six weeks of follow-up and compared them with healthy controls (HC). Associations between enzyme levels, symptom severity, and inflammatory markers were examined. The study aimed to evaluate whether α-N-acetylgalactosaminidase levels are associated with PD symptom severity and inflammatory parameters.

Official title: α-N-acetylgalactosaminidase Levels in Panic Disorder: A Prospective Observational Cohort Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

66

Start Date

2025-05-01

Completion Date

2025-08-01

Last Updated

2026-06-29

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

No intervention was assigned as part of the research protocol.

No intervention was assigned as part of the research protocol.

Locations (1)

Mehmet Hamdi ÖRÜM

Elâzığ, Elâzığ, Turkey (Türkiye)